Broken String
Broken String Biosciences provides a genomics platform centered on its INDUCE-seq technology for genome-wide on- and off-target analysis of gene editing. The company offers the BreakMap and BaseMap ABE products, which allow therapy developers to characterize DNA breaks and base editing effects in-house across various cell types and nuclease systems. Its services support drug discovery, guide optimization, and the generation of empirical data for IND-enabling studies and regulatory packages.
Visit websiteCambridge, UK
Healthtech
Biotechnology
Genomics
Life Sciences
Funding summary
- Total raised
- €14.1M
- Funding rounds
- 1
Investors in Broken String
Investors on record for Broken String. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Broken String?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors